Efficacy of itopride in functional dyspepsia patients overlapping constipation-predominant irritable bowel syndrome
10.3760/cma.j.issn.0254-1432.2010.02.008
- VernacularTitle:伊托必利治疗功能性消化不良重叠便秘型肠易激综合征疗效观察
- Author:
Huimin CHEN
;
Xiaobo LI
;
Zhimin JIANG
;
Yunjia ZHAO
;
Zhizheng GE
- Publication Type:Journal Article
- Keywords:
Functional dyspepsia;
Overlapping syndrome;
Itopride
- From:
Chinese Journal of Digestion
2010;30(2):102-105
- CountryChina
- Language:Chinese
-
Abstract:
Objective To assess the efficacy of itopride on treatment of patients with functional dyspepsia (FD) overlapping constipation-predominant irritable bowel syndrome (C-IBS). Methods Patients who met criteria for FD and FD overlapping C-IBS were randomly assigned into FD treatment group (group A), FD control group (group B), FD overlapping C-IBS treatment group (group C) and FD overlapping C-IBS control group (group D). The patients in group A and group C received 100 mg of itopride 3 times daily for 8 weeks. Dyspeptic symptoms including abdominal pain, bloating, early satiety and constipation, were evaluated before and after treatment. Ultrasonic monitoring of gastric emptying function was performed in group A and group C before and two weeks after treatment.ResultsThe symptoms of FD were relieved in both group A and group C (P<0.05), while better results were shown in group C. The significant improvement of constipation was seen in group A and group C. Besides, after medication, gastric emptying was improved in group A and group C in comparison with group B and group D. Conclusion Itopride is an effective therapeutic option in the treatmentping of patients with overlapping of FD and C-IBS.
